Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas

[1]  R. Pazdur,et al.  Fludarabine Phosphate Phase II Evaluation in Advanced Soft‐Tissue Sarcomas , 1987, American journal of clinical oncology.

[2]  R. Beart,et al.  Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. , 1987 .

[3]  R. Sylvester,et al.  Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. , 1987, European journal of cancer & clinical oncology.

[4]  P. Picci,et al.  A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Brennan,et al.  Chemotherapy for soft tissue sarcoma. , 1986, Surgery, gynecology & obstetrics.

[6]  A. Bartolucci,et al.  Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial. , 1985, Cancer treatment reports.

[7]  A. V. van Oosterom,et al.  Phase II study of elliptinium in metastatic soft tissue sarcoma. , 1985, European journal of cancer & clinical oncology.

[8]  S. Rosenberg,et al.  Patterns of recurrence in patients with high-grade soft-tissue sarcomas. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Karakousis,et al.  Metastatic patterns in soft-tissue sarcomas. , 1983, Archives of surgery.

[10]  J. Mulder,et al.  Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. , 1983, European journal of cancer & clinical oncology.

[11]  J. Tepper,et al.  Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities , 1983, Cancer.

[12]  J. Thigpen,et al.  Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study. , 1981, Cancer treatment reports.

[13]  D. V. Von Hoff,et al.  Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity. , 1979, Cancer treatment reports.

[14]  H. Ueoka,et al.  Clinical study of aclacinomycin A. , 1979, Cancer treatment reports.

[15]  S. Crooke,et al.  Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses. , 1978, Molecular pharmacology.

[16]  P. Wiernik,et al.  Phase II study of azotomycin in sarcomas. , 1977, Cancer treatment reports.

[17]  H. Pinedo,et al.  Chemotherapy of advanced soft-tissue sarcomas in adults. , 1977, Cancer treatment reviews.

[18]  H. Naganawa,et al.  New antitumor antibiotics aclacinomycins A and B. , 1975, The Journal of antibiotics.

[19]  M Zelen,et al.  The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.

[20]  R. W. Brockman,et al.  Azotomycin (NSC-56654): biologic fate in mice and man. , 1971, Cancer chemotherapy reports.

[21]  G. Ramírez,et al.  Phase II study of azotomycin (NSC-56654). , 1968, Cancer chemotherapy reports.

[22]  D. Karnofsky,et al.  Pharmacological and initial therapeutic observations on 6‐Diazo‐5‐Oxo‐L‐Norleucine (Don) in human neoplastic disease , 1957, Cancer.

[23]  David A. Amato,et al.  Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma , 2004, Investigational New Drugs.

[24]  S. Kaye,et al.  High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma , 2004, Cancer Chemotherapy and Pharmacology.

[25]  A. Giuliano,et al.  Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  R. Wittes,et al.  Clinical drug development: an analysis of phase II trials, 1970-1985. , 1987, Cancer treatment reports.

[27]  J. Koeller,et al.  Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses. , 1982, Cancer treatment reports.

[28]  H. Mouridsen,et al.  N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group. , 1982, European journal of cancer & clinical oncology.

[29]  G. Gauze,et al.  [New antitumor antibiotics 5590 and 2928]. , 1981, Antibiotiki.

[30]  H. Majima.  Preliminary clinical study of aclacinomycin A. , 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[31]  E. Casper,et al.  Phase I study of 6-diazo-5-oxo-L-norleucine (DON). , 1980, Cancer treatment reports.